Latest in Patient Experience

Pharma cybersecurity challenges: a holistic prescription

The pharmaceutical sector remains a prime target for cyberattacks. As an industry built on innovation, with extensive investments in research and development (R&D), intellectual property (IP) and patient information, it bridges the divide between business and healthcare, becoming a hotspot in the health data threat landscape

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

Industrial data mastery: navigating the 2025 landscape

As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
See more

Pharmaseal reaches milestone in crowdfunding campaign

The company was first founded in 2016

Ilya Pharma awarded engineered lactic acid bacterial strain patent

The patent covers the use of engineered lactic acid bacterial strains for all human and animal wounds, not just skin

A card in the competition for COVID-19 drug supply

The patent system has come under pressure both politically and, more recently, as pharma companies scale-up their operations to make large amounts of drugs available to treat COVID-19, reports Paul England, Senior Professional Support Lawyer at Taylor Wessing

Sigrid Therapeutics obtains US patent for silica-based biomaterial SiPore15 for the treatment and prevention of obesity

Mesoporous silica particles (MSP) are a type of ingestible synthetic amorphous silica particles that can be produced with a large surface area and a range of pore sizes

VistaGen and Nuformix agree to develop cocrystalline forms of AV-101

The drug for treatment of multiple CNS conditions will be reformed into a novel patentable form to potentially improve delivery and give more intellectual property protection

Phillips-Medisize acquires mini-tablet dispenser patent

The US company has acquired exclusive ownership of the patent from a global pharmaceutical company and expects to make the product available by early 2020

Using IP to secure opportunities in the budding medical cannabis sector

The opportunities for innovation in medical cannabis dovetails with the opportunity to obtain patent protection for the resulting inventions by pharmaceutical companies, writes Callum McGuinn, Senior Associate and European Patent Attorney, Mewburn Ellis

The new F-Gas Regulation and its impact on pharmaceutical freeze-drying

Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex, integrated system that balances both technical and biological specifications with economic, safety, and environmental concerns

Latest posts in Patient Experience

The importance of disaster resilience in the pharmaceutical industry

Changes to IP protection laws have left pharmaceutical manufacturers facing fierce competition and urgently looking for ways to streamline production, boost productivity and minimise downtime whilst adhering to a strict regulatory framework

Taking a multifaceted approach to combatting superbugs

Paul Chapman, Partner at Marks & Clerk LLP, takes a look at research underway for testing a compound on Gram-negative bacteria known for being the most difficult to treat of all infections

UK pharmaceutical patents up 20%

Innovation seen to be key as this sector continues to grow and export its technology to the wider world, reports Marks & Clerk

Why intellectual property is vital to the success of R&D

Life changing medicinal breakthroughs and cutting-edge surgical technology just would not exist without vital research and development

Locate Bio is granted key US and EU patents for its IntraStem non-viral, next generation gene delivery technology

Locate Bio, a cell and gene therapy platform company developing a pipeline of regenerative medicine products, has received notification that it will be granted key patents covering its IntraStem technology in the United States and Europe

Hikma launches Dalfampridine Extended-release tablets

Hikma Pharmaceuticals, formerly known as West-Ward Pharmaceuticals, has launched Dalfampridine Extended-release tablets, 10 mg, the generic therapeutic equivalent to Ampyra

Follicum expands patent portfolio

First diabetes patent published and promising experimental data supports new patent application

Noramco announces provisional patent application of proprietary cannabidiol (CBD)

Filing with the US Patent and Trademark Office covers pure cannabidiol compositions

Is the west set to lose the innovation arms race?

New research finds that the US, EU & UK will lose all innovation leadership positions by 2029

Grant announcement of Canadian patent by Oxford BioDynamics

The now patented technology platform, EpiSwitch, enables the high resolution discovery and monitoring of regulatory conditional chromosome conformation signatures

Licence and co-development agreement signed to develop botulinum toxin in Japan

Teijin announced it has signed an exclusive licence and co-development agreement with Merz Pharma for Xeomin (incobotulinumtoxinA), the novel type A botulinum neurotoxin, covering all expected indications for ethical pharmaceutical use in Japan

Difficulty understanding patent and IP law?

PatSnap, a specialist provider of R&D analytics, has launched PatSnap Academy, an online learning hub providing free courses on intellectual property (IP)

Sponsor content

Documentation complexity at crisis point?

Do we focus too much on the paperwork, to the detriment of product and patients? Has documentation become so complex it’s become a dangerous distraction and your biggest...

Lawsuit filed against three pharma companies for patent infringement

DSM Sinochem Pharmaceuticals has initiated patent litigation against CSPC Pharmaceutical Group, Inner Mongolia Changsheng Pharmaceutical Company and CSPC Zhangnuo...

PuriCore granted two US patents

Significantly strengthens the company’s product portfolio

Alkermes receives Notices of Allowance for US patents for four CNS pipeline candidates

Represent novel therapeutic approaches with potential to address unmet needs in their respective disease areas

Alkermes announces notice of allowance of US patent for novel fumarate prodrug

Company plans to file IND and advance MMF prodrug formulations into the clinic in mid 2014